Daniel P. Noij

Daniel P. Noij

Auto-generated profile, based on publicly available information

Daniel P. Noij

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Oral Oncology
Verified
Journal Article
Open access
DNDaniel P. Noij
Daniel P. Noij
RMRoland M. Martens
Roland M. Martens
JMJ. Tim Marcus
J. Tim Marcus
RBRemco de Bree
Remco de Bree
CLC. René Leemans
C. René Leemans
PGPim de Graaf
Pim de Graaf
Intravoxel incoherent motion (IVIM) imaging is increasingly applied in the assessment of head and neck cancer (HNC). Our purpose was to determine the diagnostic and prognostic performance of IVIM in HNC by performing a critical review of the literature. Pubmed and EMBASE were searched until May 2016. Study and patients characteristics, imaging protocol and diagnostic or prognostic outcomes were extracted by 2 independent reviewers. The studied IVIM parameters were diffusion coefficient (D), pseudodiffusion coefficient (D∗), and perfusion fraction (f). We included 10 diagnostic studies, 5 prognostic studies and 2 studies assessing both. Studies were very heterogeneous in terms of applied b-values, imaging protocols, outcome measurements and reference standards; therefore we did not perform a meta-analysis. The most commonly used sequence was "spin-echo planar imaging". A median of 10.5 b-values (range, 3-17) were used. All but three studies included at least 4 b-values below b=200s/mm2. By combining IVIM-parameters squamous cell carcinomas, lymphomas, malignant salivary gland tumors, Warthin's tumors and pleomorphic adenomas could be differentiated with a sensitivity of 85-87% and specificity of 80-100%. Low pre-treatment D or f and an increase in D during treatment were associated with a favorable response to treatment. D∗ appeared to be the parameter with the lowest prognostic value. Future research should focus on finding the optimal IVIM protocol, using uniformly accepted study methods and larger patient populations.

1 September 2003
Verified
Journal Article
Closed access
PBPontus K E Börjesson
Pontus K E Börjesson
EPErnst J Postema
Ernst J Postema
JRJan C Roos
Jan C Roos
DCDavid R Colnot
David R Colnot
HMHenri A M Marres
Henri A M Marres
GDGuus A M S Van Dongen
Guus A M S Van Dongen

1 April 2019 in European Journal of Radiology
Verified
Journal Article
Open access
RMRoland Martens
Roland Martens
DNDaniel P. Noij
Daniel P. Noij
TKThomas Koopman
Thomas Koopman
BZBen Zwezerijnen
Ben Zwezerijnen
MHMartijn Heymans
Martijn Heymans
JCJonas A. Castelijns
Jonas A. Castelijns
In head and neck squamous cell carcinoma (HNSCC) (chemo)radiotherapy is increasingly used to preserve organ functionality. The purpose of this study was to identify predictive pretreatment DWI- and 18F-FDG-PET/CT-parameters for treatment failure (TF), locoregional recurrence (LR) and death in HNSCC patients treated by (chemo)radiotherapy. We retrospectively included 134 histologically proven HNSCC patients treated with (chemo)radiotherapy between 2012-2017. In 58 patients pre-treatment DWI and 18F-FDG-PET/CT were performed, in 31 patients DWI only and in 45 patients 18F-FDG-PET/CT only. Primary tumor (PT) and largest lymph node (LN) metastasis were quantitatively assessed for TF, LR and death. Multivariate analysis was performed for 18F-FDG-PET/CT and DWI separately and thereafter combined. In patients with both imaging modalities, positive and negative predictive value in TF and differences in LR and death, were assessed. Mean follow-up was 25.6 months (interquartile-range; 14.0-37.1 months). Predictors of treatment failure, corrected for TNM-stage and HPV-status, were SUVmax-PT, ADCmax-PT, total lesion glycolysis (TLG-LN), ADCp20-LN (P = 0.049, P = 0.024, P = 0.031, P = 0.047, respectively). TLG-PT was predictive for LR (P = 0.003). Metabolic active tumor volume (MATV-PT) (P = 0.003), ADCGTV-PT (P < 0.001), ADCSD (P = 0.048) were significant predictors for death. In patients with both imaging modalities SUVmax-PT remained predictive for treatment failure (P = 0.049), TLG-LN for LR (P = 0.003) and ADCGTV-PT for death (P < 0.001). Higher predictive value for treatment failure was found for the combination of SUVmax-PT and ADCmax-PT, compared to either one separately. Both DWI- and 18F-FDG-PET/CT-parameters appear to have predictive value for treatment failure, locoregional recurrence and death. Combining SUVmax-PT and ADCmax-PT resulted in better prediction of treatment failure compared to single parameter assessment.

1 September 2012 in Oral Oncology
Verified
Journal Article
Closed access
MHMissak Haigentz
Missak Haigentz
DHDana M. Hartl
Dana M. Hartl
CSCarl E. Silver
Carl E. Silver
HLHans Langendijk
Hans Langendijk
Remco De BreeRemco De Bree
Remco De Bree
Alfio FerlitoAlfio Ferlito
Alfio Ferlito


1 February 2015 in Oral Oncology
Verified
Journal Article
Closed access
DNDaniel P. Noij
Daniel P. Noij
MJMarcus C. de Jong
Marcus C. de Jong
LMLieven G.M. Mulders
Lieven G.M. Mulders
JMJohannes T. Marcus
Johannes T. Marcus
Remco De BreeRemco De Bree
Remco De Bree
JCJonas A. Castelijns
Jonas A. Castelijns